CRQ Survey Study: Clinical Research Questionnaire of Oncology Patients - A Nationwide Survey

Completed

• Conditions: Cancer

• Registration Number: NCT02836392
• Lead Sponsor: Cancer Trials Ireland

Brief Summary

This is a translational, multicentre questionnaire study. The study design follows that of a cross sectional, quantitative research approach. Data collection will involve self-administered, paper-based questionnaires. The method of data collection allows for a large sample size without major expense. The questionnaires are comprised of several questions examining areas such as demographic details, cancer diagnosis, understanding of the term 'clinical trials', attitudes to personal participation in cancer clinical research and the experience of patients who previously participated in a cancer clinical trial. The study will be opened in all interested hospitals in Ireland following initiation of the study at each site. Questionnaire completion will be seen as implied informed consent and no formal consent will need to be signed by the patient. The paper-based questionnaire responses will be electronically and anonymously recorded in a computer database to facilitate analysis.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-05
• Study First Submitted: 2016-06-27
• Study First Submitted QC: 2016-07-18
• Study First Posted: 2016-07-19
• Primary Completion: 2016-12
• Study Completion: 2017-01
• Status Verified: 2017-08
• Last Update Submitted: 2017-08-09
• Last Update Posted: 2017-08-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• Clinical diagnosis of malignancy
• Aged 18 years or older
• Ability to complete the questionnaire or independently or with the help of a friend, relative, or staff member of the oncology department

Exclusion Criteria

• N/A

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Oncology patients' understanding of the term 'clinical trials' and their attitudes towards personal participation in cancer clinical research will be evaluated by questionnaire.	1 year

Secondary Outcome Measures

Name	Time	Method
The patient related factors, including level of education and socioeconomic status that influence their decision regarding participation in a cancer clinical trial (CCT) will be explored by questionnaire.	1 year
The patients' experience surrounding the discussion regarding CCT participation and their actual experience when enrolled in a CCT will be investigated by questionnaire.	1 year

Trial Locations

Locations (14)

University Hospital Waterford; 🇮🇪 Waterford, Co Waterford, Ireland

AMNCH; 🇮🇪 Tallaght, Dublin 24, Ireland

St Vincent's University Hospital; 🇮🇪 Elm Park, Dublin 4, Ireland

Bon Secours Hospital; 🇮🇪 Cork, Ireland

Cork University Hospital; 🇮🇪 Cork, Ireland

Beaumont Hospital; 🇮🇪 Beaumont Road, Dublin, Ireland

Beacon Hospital; 🇮🇪 Dublin, Ireland

Saint Luke's Hospital Rathgar; 🇮🇪 Dublin, Ireland

Mater Misericordiae University Hospital; 🇮🇪 Dublin, Ireland

St James Hospital; 🇮🇪 Dublin, Ireland

University Hospital Limerick; 🇮🇪 Limerick, Ireland

University Hospital Galway; 🇮🇪 Galway, Ireland

Letterkenny General Hospital; 🇮🇪 Letterkenny, Ireland

Sligo University Hospital; 🇮🇪 Sligo, Ireland